Universal Beteiligungs und Servicegesellschaft mbH Has $62.59 Million Stake in CVS Health Corporation $CVS

Universal Beteiligungs und Servicegesellschaft mbH increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 830,232 shares of the pharmacy operator’s stock after buying an additional 20,082 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.07% of CVS Health worth $62,591,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. Norges Bank acquired a new position in CVS Health in the second quarter valued at about $1,358,698,000. Invesco Ltd. increased its holdings in CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after buying an additional 3,118,626 shares during the period. Robeco Institutional Asset Management B.V. raised its position in shares of CVS Health by 815.2% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock valued at $183,701,000 after buying an additional 2,372,121 shares in the last quarter. Jennison Associates LLC lifted its holdings in shares of CVS Health by 111.7% during the 2nd quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock worth $276,895,000 after acquiring an additional 2,117,798 shares during the period. Finally, Vanguard Group Inc. boosted its position in shares of CVS Health by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after acquiring an additional 2,063,737 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the subject of several research analyst reports. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Robert W. Baird lifted their price target on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Argus upped their price objective on CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Piper Sandler reissued an “overweight” rating and set a $101.00 target price (up previously from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Trading Up 1.7%

Shares of CVS stock opened at $81.49 on Thursday. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $103.44 billion, a P/E ratio of 214.44, a P/E/G ratio of 0.74 and a beta of 0.48. CVS Health Corporation has a twelve month low of $52.34 and a twelve month high of $85.15. The stock’s fifty day simple moving average is $78.88 and its 200 day simple moving average is $74.56.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the firm posted $1.09 earnings per share. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date is Thursday, January 22nd. CVS Health’s dividend payout ratio is 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.